Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo.
Meltzer EO, Bachert C, Staudinger H. Meltzer EO, et al. J Allergy Clin Immunol. 2005 Dec;116(6):1289-95. doi: 10.1016/j.jaci.2005.08.044. Epub 2005 Oct 24. J Allergy Clin Immunol. 2005. PMID: 16337461 Clinical Trial.
Efficacy and safety of Azmacort MDI and Flovent Diskhaler.
Deslandes B, Lim J, Staudinger H. Deslandes B, et al. J Allergy Clin Immunol. 1998 Jul;102(1):154-5. doi: 10.1016/s0091-6749(98)70072-7. J Allergy Clin Immunol. 1998. PMID: 9679864 No abstract available.
A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
Bousquet J, Gaudaño EM, Palma Carlos AG, Staudinger H. Bousquet J, et al. Allergy. 1999 Jun;54(6):562-8. doi: 10.1034/j.1398-9995.1999.00984.x. Allergy. 1999. PMID: 10435469 Clinical Trial.
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
Bachert C, Hellings PW, Mullol J, Hamilos DL, Gevaert P, Naclerio RM, Joish VN, Chao J, Mannent LP, Amin N, Abbe A, Taniou C, Fan C, Pirozzi G, Graham NMH, Mahajan P, Staudinger H, Khan A. Bachert C, et al. Among authors: staudinger h. Allergy. 2020 Jan;75(1):148-157. doi: 10.1111/all.13984. Epub 2019 Oct 23. Allergy. 2020. PMID: 31306495
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.
Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A. Weinstein SF, et al. J Allergy Clin Immunol. 2018 Jul;142(1):171-177.e1. doi: 10.1016/j.jaci.2017.11.051. Epub 2018 Jan 31. J Allergy Clin Immunol. 2018. PMID: 29355679 Clinical Trial.
BACKGROUND: Dupilumab, an anti-IL-4 receptor α mAb, inhibits IL-4/IL-13 signaling, key drivers of type 2/T(H)2 immune diseases (eg, atopic/allergic disease). ...
BACKGROUND: Dupilumab, an anti-IL-4 receptor α mAb, inhibits IL-4/IL-13 signaling, key drivers of type 2/T(H)2 immune diseases (eg, a …
A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber.
Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Yao R, Staudinger H, Danzig M. Horak F, et al. Ann Allergy Asthma Immunol. 2009 Feb;102(2):116-20. doi: 10.1016/S1081-1206(10)60240-2. Ann Allergy Asthma Immunol. 2009. PMID: 19230461 Clinical Trial.
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.
Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C. Gevaert P, et al. J Allergy Clin Immunol. 2006 Nov;118(5):1133-41. doi: 10.1016/j.jaci.2006.05.031. Epub 2006 Sep 26. J Allergy Clin Immunol. 2006. PMID: 17088140 Clinical Trial.
Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H. Berger WE, et al. Ann Allergy Asthma Immunol. 2006 Nov;97(5):672-80. doi: 10.1016/S1081-1206(10)61099-X. Ann Allergy Asthma Immunol. 2006. PMID: 17165278 Clinical Trial.
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A. Castro M, et al. N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21. N Engl J Med. 2018. PMID: 29782217 Clinical Trial.
Safety of desloratadine syrup in children.
Bloom M, Staudinger H, Herron J. Bloom M, et al. Curr Med Res Opin. 2004 Dec;20(12):1959-65. doi: 10.1185/030079904x14148. Curr Med Res Opin. 2004. PMID: 15701213 Clinical Trial.
217 results
Jump to page
Feedback